title: Metallocenes as Target Specific Drugs for Cancer Treatment.
abstract: The application use of organometallic compounds into the cancer research was established in the late 1970s by Köpf-Maeir and Köpf. This new research area has been developed for the past thirty years. In the early 1980s, Jaouen and coworkers recognized the potential application of organometallic compounds vectorized with pendant groups that can deliver the drug to certain specific receptors. This is what is called nowdays Target Specific Drugs. This review will focus on metallocenes vectorized with steroids derivatives of hormones, nonsteroidal and selective endrocrine modulator.
authors.affiliation: University of Puerto Rico, Department of Chemistry, PO Box 9019 Mayagüez, PR 00681.
authors.forename: Enrique
authors.initials: E
authors.lastname: Meléndez